Clinical Trial Update: Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteries [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 trial update reporting on the safety and efficacy of the ZoMaxx drug-eluting stent system in coronary arteries, with the trial status shown as c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Restenosis

Drugs mentioned

• ZoMaxx Drug-Eluting Stent System

Snippet

Sponsor: Abbott Medical Devices | Conditions: Coronary Disease, Coronary Artery Disease | Phase 2, Phase 3 | Status: COMPLETED